{
    "2021-03-23": [
        [
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：公司募投项目正在进行",
                "features": {
                    "keywords": [
                        "募投项目",
                        "进行"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：公司二价HPV疫苗正常销售",
                "features": {
                    "keywords": [
                        "二价HPV疫苗",
                        "正常销售"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：公司带状疱疹疫苗项目已终止研发 项目问题",
                "features": {
                    "keywords": [
                        "带状疱疹疫苗",
                        "终止研发",
                        "项目问题"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：二价疫苗目前年产能1000万人份",
                "features": {
                    "keywords": [
                        "二价疫苗",
                        "年产能",
                        "1000万人份"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：公司有生产新冠检测试剂",
                "features": {
                    "keywords": [
                        "新冠检测试剂",
                        "生产"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：九价宫颈癌疫苗已经进入三期临床",
                "features": {
                    "keywords": [
                        "九价宫颈癌疫苗",
                        "三期临床"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：二价宫颈癌疫苗的世卫组织认证正在推进中，受疫情影响，稍有推迟",
                "features": {
                    "keywords": [
                        "二价宫颈癌疫苗",
                        "世卫组织认证",
                        "推进",
                        "疫情",
                        "推迟"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：公司新冠试剂以销定产，目前能够满足销售需要",
                "features": {
                    "keywords": [
                        "新冠试剂",
                        "以销定产",
                        "满足销售需要"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：九价HPV疫苗目前已进入三期临床，具体上市时间无法预计",
                "features": {
                    "keywords": [
                        "九价HPV疫苗",
                        "三期临床",
                        "上市时间",
                        "无法预计"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：2价HPV疫苗的WHO PQ工作正常推进中",
                "features": {
                    "keywords": [
                        "2价HPV疫苗",
                        "WHO PQ",
                        "正常推进"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "万泰生物：2价HPV疫苗年产能1000万人份，预计未来扩大到3000万人份",
                "features": {
                    "keywords": [
                        "2价HPV疫苗",
                        "年产能",
                        "1000万人份",
                        "3000万人份"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "医药与健康护理行业周报：估值风险有效控制 关注业绩高增长公司",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "估值风险",
                        "业绩高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}